UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue — Pittsburgh, Pennsylvania

UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue has participated in 4 clinical trials.

Therapeutic areas: COVID-19, Covid19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue?

UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue conducted?

UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue has 4 clinical trials on record. Their work covers COVID-19, Covid19.

Is UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue accredited by Crixeo Clinical Trials?

UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.